Clinical Trials
24
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers
- Conditions
- Venus Leg Ulcers
- Interventions
- Drug: EscharEx (EX-03)Drug: Placebo (Gel vehicle)
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- MediWound Ltd
- Target Recruit Count
- 45
- Registration Number
- NCT06690177
- Locations
- 🇺🇸
ILD Research Center, Carlsbad, California, United States
🇵🇱Wojskowy Instytut Medyczny, Warsaw, Poland
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
- Conditions
- Venous Leg Ulcer (VLU)
- Interventions
- Drug: EscharEx (EX-03)Drug: Placebo (Gel vehicle)
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- MediWound Ltd
- Target Recruit Count
- 216
- Registration Number
- NCT06568627
- Locations
- 🇺🇸
Limb Preservation Platform, Inc, Fresno, California, United States
🇺🇸Center for Clinical Research INC, San Francisco, California, United States
🇺🇸Northwell Health Comprehensive Wound Healing Center, Lake Success, New York, United States
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
- Conditions
- Nodular Basal Cell CarcinomaSuperficial Basal Cell Carcinoma
- Interventions
- Drug: EscharEx 5% (EX-02 formulation)
- First Posted Date
- 2021-12-15
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- MediWound Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT05157763
- Locations
- 🇺🇸
Center for Clinical and Cosmetic Research, Aventura, Florida, United States
🇺🇸Moore Clinical Research, Inc., Brandon, Florida, United States
🇺🇸Center for Clinical Studies, LTD. LLP, Webster, Texas, United States
A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers
- Conditions
- Venous Leg UlcerDiabetic Foot Ulcer
- Interventions
- Drug: EscharEx (EX-02 formulation)
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- MediWound Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT04817228
- Locations
- 🇺🇸
Barry University foot and ankle institute, Tamarac, Florida, United States
🇺🇸Clinical Research Medical Center, LLC, Las Vegas, Nevada, United States
🇺🇸University of North Carolina, Chapel Hill, North Carolina, United States
Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries
- Conditions
- Thermal Burn
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- MediWound Ltd
- Registration Number
- NCT04040660
- Locations
- 🇺🇸
University of South Alabama, Mobile, Alabama, United States
🇺🇸Valleywise Health Medical Center, Phoenix, Arizona, United States
🇺🇸University of California, Irvine, Orange, California, United States
- Prev
- 1
- 2
- 3
- Next